STOCK TITAN

Vireo Health to Report First Quarter 2021 Results on May 14, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vireo Health International, a science-focused cannabis company, will announce its financial results for Q1 2021 on May 14, 2021, before market opens. The conference call will occur at 8:30 a.m. ET on the same day, allowing stakeholders to gain insights into the company's performance. Interested participants can register for the call via a specific link. Vireo operates in eight markets and manages 16 dispensaries, aiming for efficiency and innovation in cannabis production. For more details, visit vireohealth.com.

Positive
  • None.
Negative
  • None.

MINNEAPOLIS, May 4, 2021 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO, OTCQX: VREOF), the leading physician-founded, science-focused multi-state cannabis company, today announced that it will report financial results for its first quarter ended March 31, 2021 on Friday, May 14, 2021 before the market opens.  

The Company will hold a conference call and webcast to discuss its business and financial results that same day at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). Interested parties may register to attend the call via this link: http://www.directeventreg.com/registration/event/2254847.

Upon registration, each participant will be provided with call details and a registrant ID for Vireo's conference ID number 2254847. A live audio webcast of the call will also be available in the Events & Presentations section of Vireo's website at https://investors.vireohealth.com/events-and-presentations/default.aspx. A webcast replay will be made available for one year on Vireo's website.

About Vireo Health International, Inc.

Vireo Health International, Inc. is a physician-led cannabis company focused on bringing the best of technology, science, and engineering to the cannabis industry. Vireo manufactures proprietary, branded cannabis products in environmentally friendly facilities, state-of-the-art cultivation sites and distributes its products through its growing network of Green Goods™ and other retail locations and third-party dispensaries. Vireo's team of more than 400 employees, led by scientists, engineers, and cultivation experts, is focused on efficiency and the creation of best-in-class products, while driving scientific innovation within the cannabis industry and developing meaningful intellectual property. Today, Vireo is licensed to grow and/or process cannabis in eight markets and operates 16 dispensaries nationwide. For more information about Vireo Health, please visit www.vireohealth.com.

Contact Information            

Investor Inquiries 
Sam Gibbons
Vice President, Investor Relations
samgibbons@vireohealth.com 
(612) 314-8995

Media Inquiries 
Albe Zakes 
Vice President, Corporate Communications  
albezakes@vireohealth.com   
(267) 221-4800

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/vireo-health-to-report-first-quarter-2021-results-on-may-14-2021-301282985.html

SOURCE Vireo Health International, Inc.

FAQ

When will Vireo Health report its financial results for Q1 2021?

Vireo Health will report its Q1 2021 financial results on May 14, 2021, before market opens.

What time is Vireo Health's conference call on May 14, 2021?

The conference call will be held at 8:30 a.m. Eastern Time on May 14, 2021.

How can I attend Vireo Health's conference call?

You can register to attend Vireo Health's conference call via the link provided in their press release.

Where can I find Vireo Health's financial results after they are announced?

A webcast replay of Vireo Health's financial results will be available for one year on their website.

What is Vireo Health's focus as a cannabis company?

Vireo Health focuses on leveraging technology, science, and engineering within the cannabis industry.

In how many markets does Vireo Health operate?

Vireo Health is licensed to grow and process cannabis in eight markets.

VIREO GROWTH INC

OTC:VREOF

VREOF Rankings

VREOF Latest News

VREOF Stock Data

80.89M
77.84M
17.73%
23.61%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Minneapolis